Cambridge Investment Research Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.08M | Buy |
11,553
+477
| +4% | +$129K | 0.01% | 1263 |
|
|
2025
Q4 | $2.78M | Buy |
11,076
+643
| +6% | +$171K | 0.01% | 1271 |
|
|
2025
Q3 | $3M | Buy |
10,433
+119
| +1% | +$31.9K | 0.01% | 1217 |
|
|
2025
Q2 | $2.71M | Buy |
10,314
+239
| +2% | +$58.2K | 0.01% | 1212 |
|
|
2025
Q1 | $2.35M | Buy |
10,075
+92
| +0.9% | +$22.3K | 0.01% | 1245 |
|
|
2024
Q4 | $2.29M | Buy |
9,983
+1,070
| +12% | +$245K | 0.01% | 1268 |
|
|
2024
Q3 | $1.99M | Buy |
8,913
+510
| +6% | +$112K | 0.01% | 1347 |
|
|
2024
Q2 | $1.71M | Sell |
8,403
-528
| -6% | -$107K | 0.01% | 1390 |
|
|
2024
Q1 | $1.95M | Buy |
8,931
+862
| +11% | +$190K | 0.01% | 1272 |
|
|
2023
Q4 | $1.83M | Sell |
8,069
-198
| -2% | -$41.6K | 0.01% | 1255 |
|
|
2023
Q3 | $1.66M | Sell |
8,267
-1,003
| -11% | -$212K | 0.01% | 1255 |
|
|
2023
Q2 | $1.92M | Sell |
9,270
-203
| -2% | -$39.4K | 0.01% | 1195 |
|
|
2023
Q1 | $1.87M | Sell |
9,473
-1,203
| -11% | -$248K | 0.01% | 1164 |
|
|
2022
Q4 | $2.16M | Sell |
10,676
-690
| -6% | -$135K | 0.01% | 1035 |
|
|
2022
Q3 | $2M | Sell |
11,366
-15,600
| -58% | -$3.19M | 0.01% | 1029 |
|
|
2022
Q2 | $5.43M | Buy |
26,966
+15,707
| +140% | +$3.35M | 0.03% | 554 |
|
|
2022
Q1 | $2.55M | Sell |
11,259
-1,173
| -9% | -$276K | 0.01% | 1003 |
|
|
2021
Q4 | $3.36M | Sell |
12,432
-1,020
| -8% | -$253K | 0.02% | 853 |
|
|
2021
Q3 | $3.25M | Buy |
13,452
+1,355
| +11% | +$341K | 0.02% | 827 |
|
|
2021
Q2 | $2.87M | Sell |
12,097
-369
| -3% | -$84.1K | 0.01% | 924 |
|
|
2021
Q1 | $2.73M | Buy |
12,466
+325
| +3% | +$65.2K | 0.01% | 851 |
|
|
2020
Q4 | $2.12M | Sell |
12,141
-2,918
| -19% | -$504K | 0.01% | 894 |
|
|
2020
Q3 | $2.44M | Buy |
15,059
+964
| +7% | +$153K | 0.02% | 710 |
|
|
2020
Q2 | $2.01M | Buy |
14,095
+4,170
| +42% | +$577K | 0.02% | 773 |
|
|
2020
Q1 | $1.08M | Sell |
9,925
-1,341
| -12% | -$193K | 0.01% | 935 |
|
|
2019
Q4 | $1.64M | Buy |
11,266
+1,966
| +21% | +$284K | 0.01% | 883 |
|
|
2019
Q3 | $1.34M | Sell |
9,300
-234
| -2% | -$34.1K | 0.01% | 922 |
|
|
2019
Q2 | $1.42M | Buy |
9,534
+423
| +5% | +$59K | 0.01% | 868 |
|
|
2019
Q1 | $1.2M | Buy |
9,111
+87
| +1% | +$10.7K | 0.01% | 950 |
|
|
2018
Q4 | $980K | Buy |
9,024
+3,862
| +75% | +$517K | 0.01% | 945 |
|
|
2018
Q3 | $770K | Buy |
5,162
+138
| +3% | +$21K | 0.01% | 1188 |
|
|
2018
Q2 | $775K | Buy |
5,024
+78
| +2% | +$11.8K | 0.01% | 1129 |
|
|
2018
Q1 | $687K | Buy |
4,946
+204
| +4% | +$30K | 0.01% | 1152 |
|
|
2017
Q4 | $650K | Buy |
4,742
+240
| +5% | +$31.7K | 0.01% | 1160 |
|
|
2017
Q3 | $584K | Buy |
4,502
+137
| +3% | +$18.3K | 0.01% | 1160 |
|
|
2017
Q2 | $578K | Sell |
4,365
-457
| -9% | -$56K | 0.01% | 1105 |
|
|
2017
Q1 | $594K | Buy |
4,822
+36
| +0.8% | +$4.26K | 0.01% | 984 |
|
|
2016
Q4 | $528K | Sell |
4,786
-249
| -5% | -$27.7K | 0.01% | 980 |
|
|
2016
Q3 | $595K | Buy |
5,035
+774
| +18% | +$91.2K | 0.01% | 941 |
|
|
2016
Q2 | $477K | Buy |
4,261
+167
| +4% | +$18K | 0.01% | 954 |
|
|
2016
Q1 | $412K | Buy |
4,094
+559
| +16% | +$53.6K | 0.01% | 1004 |
|
|
2015
Q4 | $375K | Buy |
3,535
+649
| +22% | +$67K | 0.01% | 1011 |
|
|
2015
Q3 | $269K | Buy |
2,886
+23
| +0.8% | +$2.38K | 0.01% | 1077 |
|
|
2015
Q2 | $298K | Buy |
2,863
+129
| +5% | +$13.4K | 0.01% | 1063 |
|
|
2015
Q1 | $296K | Buy |
2,734
+263
| +11% | +$27K | 0.01% | 1059 |
|
|
2014
Q4 | $229K | Buy |
+2,471
| New | +$218K | 0.01% | 1140 |
|
Other funds holding LH
VCM
VPM
Cambridge Investment Research Advisors's LH Position: Q1 2026 in Review
Cambridge Investment Research Advisors increased its Labcorp (LH) stake by 4.3% in Q1 2026, buying an estimated $129K and bringing the position to 11,553 shares worth $3.08M. The position accounts for 0.01% of the portfolio, ranked #1263.
Cambridge Investment Research Advisors first reported a position in LH in Q4 2014 and has held it in 46 quarters since. The position peaked at $5.43M in Q2 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Cambridge Investment Research Advisors held 11,553 shares of Labcorp worth $3.08M as of Q1 2026.
- Cambridge Investment Research Advisors bought 477 Labcorp shares in Q1 2026, an estimated $129K.
- Labcorp made up 0.01% of Cambridge Investment Research Advisors's portfolio in Q1 2026, its #1263 holding.
- Cambridge Investment Research Advisors first reported a position in Labcorp in Q4 2014 and has held it in 46 quarters since.
- Cambridge Investment Research Advisors's Labcorp position peaked at $5.43M in Q2 2022.
- 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Cambridge Investment Research Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.